Population screening in a Druze community: The challenge and the reward

Genetics in Medicine

Volumn 10, Issue 12, 2008, Pages 903-909

  Falik Zaccai, Tzipora C ^a,b   Kfir, Nechama ^a   Frenkel, Pnina ^a   Cohen, Cindy ^a   Tanus, Mary ^c   Mandel, Hanna ^b,d   Shihab, Shihab ^c   Morkos, Siman ^e   Aaref, Salameh ^e   Summar, Marshall L ^f   Khayat, Morad ^a  

^a WESTERN GALILEE HOSPITAL   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^c MINISTRY OF HEALTH   (Israel)

^d RAMBAM MEDICAL CENTER   (Israel)

^e Sherutei Briut Clalit ^*  (Israel)

^f VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Argininosuccinate lyase deficiency; Carbamyl phosphate synthetase I deficiency; Cerebrotendinous xanthomatosis; Population screening; Prolidase deficiency

Indexed keywords

ARGININOSUCCINATE LYASE DEFICIENCY; ARTICLE; BIRTH DEFECT; CARBAMYL PHOSPHATE SYNTHETASE DEFICIENCY; CEREBROTENDINOUS XANTHOMATOSIS; ENZYME DEFICIENCY; FEMALE; GENE MUTATION; GENETIC COUNSELING; GENETIC SCREENING; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; PROLINE DIPEPTIDASE DEFICIENCY; PROPHYLAXIS; RISK ASSESSMENT;

ARGININOSUCCINATE LYASE; CARBAMOYL-PHOSPHATE SYNTHASE I DEFICIENCY DISEASE; CONSANGUINITY; DIPEPTIDASES; FEMALE; GENETIC COUNSELING; GENETIC SCREENING; HUMANS; MIDDLE EAST; POPULATION GROUPS; XANTHOMATOSIS, CEREBROTENDINOUS;

EID: 58149270935     PISSN: 10983600     EISSN: None     Source Type: Journal    
DOI: 10.1097/GIM.0b013e31818d0e0f     Document Type: Article

References (33)

1. Shlush LI, Behar DM, Yudkovsky G, et al. The Druze: a population genetic refugium of the Near East. PloS ONE 2008;3:e2105.
2. Vardi-Saliternik R, Friedlander Y, Cohen T. Consanguinity in a population sample of Israeli Muslim Arabs, Christian Arabs, and Druze. Ann Hum Biol 2002;29:422-431.
3. Cohen T, Vardi-Saliternik R, Friedlander Y. Consanguinity, intracommunity and intercommunity marriages in a population sample of Israeli Jews. Ann Hum Biol 2004;31:38-48.
4. Jaber L, Merlob P, Bu X, Rotter JI, Shohoat M. Marked parental consanguinity as a cause for increased major malformations in an Israeli Arab community. Am J Med Genet 1992;44:1-6.
5. Jaber L, Merlob P, Gabriel R, Shohat M. Effects of consanguineous marriage on reproductive outcome in an Arab community in Israel. J Med Genet 1997;34:1000-1002.
6. Stoll C, Alembik Y, Roth MP, Dott B. Parental consanguinity as a cause for increased incidence of birth defects in a study of 238,942 consecutive births. Ann Genet 1999; 42:133-139.
7. Zlotogora J. Research letter: what is the birth defect risk associated with consanguineous marriages? Am J Med Genet 2002;109:70-71.
8. Zlotogora J, Haklai Z, Rotem N, et al. Relative prevalence of malformations at birth among different religious communities in Israel. Am J Med Genet A 2003;122:59-62.
9. Kaback M, Lim-Steele J, Dabholkar D, Brown D, Levy N, Zieger K. Tay-Sachs disease: carrier screening, prenatal diagnosis, and the molecular era. JAMA 1993;270:2307-2315.
10. Mitchell JJ, Capua A, Clow C, Scriver CR. Twenty-year outcome analysis of genetic screening programs for tay-Sachs and B-Thalassemia disease carriers in high schools. Am J Hum Genet 1996;59:793-398.
11. Ostrowsky JT, Lippman A, Scriver CR. Cost-benefit analysis of a thalassemia disease prevention program. Am J Public Health 1985;75:732-736.
12. Khoury MJ, McCabe LL, McCabe ERT. Population screening in the age of genomic medicine. N Engl J Med 2003;348:50-58.
13. Pletcher BA, Gross SJ, Monaghan KG, Driscoll DA, Watson MS. The future is now: carrier screening for all populations. Genet Med 2008;10:33-36.
14. Shalev SA, Carmi R, Leventhal A, Zlotogora J. A comprehensive program for prevention of genetic disease among Arabs in Israel. Harefuah 2003;142:792-794.
15. Bach G, Zeigler M, Zlotogora M. Prevention of lysosomal storage disorders in Israel. Mol Genet Metab 2007;90:353-357.
16. Basel-Vanagaite L, Taub E, Halpern GJ, et al. Genetic screening for autosomal recessive nonsyndromic mental retardation in an isolated population in Israel. Eur J Hum Genet 2007;15:250-253.
17. Leitersdorf E, Safadi R, Meiner V, et al. Cerebrotendinous xanthomatosis in the Israeli Druze: molecular genetics and phenotypic characteristics. Am J Hum Genet 1994;55:907-915.
18. Berginer VM, Gross B, Morad K, et al. Chronic diarrhea and juvenile cataracts: think cerebrotendinous xanthomatosis and treat. Pediatrics. In press.
19. Mandel H, Abeling N, Gutman A, et al. Prolidase deficiency among an Israeli population: prenatal diagnosis in a genetic disorder with uncertain prognosis. Prenat Diag 2000;20:927-929.
20. Hershkovitz T, Hassoun G, Indelman M, et al. A homozygous missense mutation in PEPD encoding peptidase D causes prolidase deficiency associated with hyper-IgE syndrome. Clin Exp Dermatol 2006;31:435-440.
21. Linnebank M, Tschiedel E, Haberle J, et al. Arginiosuccinate lyase (ASL) deficiency: mutation analysis in 27 patients and a completed structure of the human ASL gene. Hum Genet 2002;111:350-359.
22. Salen G, Meriwether TW, Nicolau G. Chenodeoxycholic acid inhibits increased cholesterol and cholestanol synthesis in cerebrotendinous xanthomatosis. Biochem Med 1975;14:57-74.
23. Zlotogora J, Shalev S, Habiballah H, Barjes S. Genetic disorders among Palestinian Arabs: 3. Autosomal recessive disorders in a single village. Am J Med Genet 2000;92:343-345.
24. Al-Gazali L, Hamamy H, Al-Arrayad S. Genetic disorders in the Arab world. BMJ 2006;333:831-834.
25. Zlotogora J, van Baal S, Patrinos GP. Documentation of inherited disorders and mutation frequencies in the different religious communities in Israel in the Israeli National Genetic Database. Human Mutat 2007;28:944-949.
26. Alwan A, Modell B. Recommendations for introducing genetics services in developing countries. Nat Rev Genet 2003;4:61-68.
27. Saadallah AA, Rashed MS. Newborn screening: experiences in the Middle East and North Africa. J Inherit Metab Dis 2007;30:482-489.
28. Lorincz MT, Rainier S, Thomas D, Fink JK. Cerebrotendinous xanthomatosis: possible higher prevalence than previously recognized. Arc Neurol 2005;62:1459-1463.
29. Zlotogora J. Research letter: is there an increased birth defect risk to children born to offspring of first cousin parents? Am J Med Genet 2005;137A:342.
30. Zlotogora J. Parental decisions to abort or continue a pregnancy with an abnormal finding after an invasive prenatal test. Prenat Diagn 2002;22:1102-1106.
31. Sher C, Romano-Zelekha O, Green MS, Shohat T. Utilization of prenatal genetic testing by Israeli Moslem women: a national survey. Clin Genet 2004;65:278-283.
32. Canter JA, Summar ML, Smith HB, et al. Genetic variation in the mitochondrial enzyme carbamyl-phosphate synthetase I predisposes children to increased pulmonary artery pressure following surgical repair of congenital heart defects: a validated genetic association study. Mitochondrion 2007;7:204-210.
33. Seyama Y. Cholestanol metabolism, molecular pathology, and nutritional implications. J Med Food 2003;6:217-224.